Why Xylem shares fell
Xylem shares fell 8.2% on Tuesday after the company cut its 2026 revenue and adjusted earnings outlook alongside its third-quarter results. That is the clearest explanation supported by the available evidence: a report also linked the decline to the revenue shortfall, though the company’s release confirms the results and revised outlook, not the market’s reason for reacting.
Xylem now expects full-year revenue of about $8.95 billion, down 1.0% year on year, compared with its prior forecast for 2.0% growth. It also reduced its adjusted earnings-per-share range to $5.40–$5.45 from $5.55–$5.70.
Third-quarter revenue was $2.2 billion, down 3.0% on a reported basis and flat organically. Adjusted earnings per share were $1.44, up 5.0%. Orders rose 7.0% reported and 10.0% organically, while the company described a more cautious spending environment and cited project timing as a drag on revenue.
How unusual the move was
The fall was 5.2x typical daily moves for Xylem, against a typical daily move of 1.6% over the past year. It was the largest decline of this scale since 3 February 2022.
The broader market and the covered industrial machinery group rose on the same session: the S&P 500 proxy rose 0.3%, while the industry median rose 0.4%. Trading volume was 0.3x of its 30-day average, which is subdued relative to that benchmark.
What the operating figures show
The cut in the outlook sits against a stronger recent margin trend. Through the second quarter, trailing-twelve-month revenue was $9.1 billion and grew 4.5% year on year. Operating margin reached 14.5%, up 2.1 percentage points year on year. Free cash flow was $960.0 million, with a 10.5% margin.
These figures use a period ending before the third-quarter release. They therefore provide context for Xylem’s operating position, not a rebuttal to the new guidance. The release also reported stronger quarterly orders, which may support later revenue, but it described project timing and cautious customer spending as factors affecting current sales.
What it means for value
The reduced outlook bears most directly on the growth assumptions used in a discounted cash flow model. Xylem’s base-case stage-one growth assumption is 4.5%; a 5 percentage-point reduction in growth changes model value by −28.3%, while a 5 percentage-point increase changes it by +37.0%. A 1 percentage-point increase in the discount rate changes model value by −16.4%.
The model’s value per share is $83.00. These are model values under stated assumptions, not a comparison with the share price.
The other reading
The release also presents evidence against treating the quarter as a broad deterioration in operating performance: orders increased, adjusted earnings per share rose, and adjusted EBITDA margin expanded. Xylem said productivity savings and price realization outweighed inflation, lower volumes and mix.
For now, the decline is best understood in the context of lower revenue and the company’s reduced full-year expectations.